|
US5981481A
(en)
|
1974-12-06 |
1999-11-09 |
The Johns Hopkins University |
Human C3b/C4b receptor (CR1)
|
|
JPH0742235B2
(ja)
|
1985-11-08 |
1995-05-10 |
三共株式会社 |
自己免疫性疾病の予防・治療剤
|
|
DE3600368C1
(de)
|
1986-01-09 |
1987-04-02 |
Goldschmidt Ag Th |
Trennmittel fuer Polyurethanformteile
|
|
IL89790A
(en)
|
1988-04-01 |
2002-05-23 |
Johns Hopking University |
Nucleic acid sequences that encode and cells that produce cr1 protein and methods of production and purification
|
|
US6458360B1
(en)
|
1990-04-25 |
2002-10-01 |
The Johns Hopkins University |
Soluble complement regulatory molecules
|
|
WO1992010205A1
(en)
|
1990-12-06 |
1992-06-25 |
T Cell Sciences, Inc. |
Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
|
|
US5833989A
(en)
|
1992-06-24 |
1998-11-10 |
Adprotech Plc |
Soluble CR1 derivatives
|
|
GB9301289D0
(en)
|
1993-01-22 |
1993-03-17 |
Smithkline Beecham Plc |
Novel composition
|
|
US5679546A
(en)
|
1993-09-24 |
1997-10-21 |
Cytomed, Inc. |
Chimeric proteins which block complement activation
|
|
US5648244A
(en)
|
1993-09-27 |
1997-07-15 |
President And Fellows Of Harvard College |
Production, purification, cleavage and use of fusion peptides
|
|
WO1999044625A1
(en)
|
1998-03-03 |
1999-09-10 |
John Hopkins University |
Smallpox inhibitor of complement enzymes (spice) protein and methods of inhibiting complement activation
|
|
AU4452100A
(en)
|
1999-04-09 |
2000-11-14 |
Washington University |
Modified complement system regulators
|
|
MXPA01011563A
(es)
|
2000-03-13 |
2004-09-27 |
St Vincents Hosp Melbourne Ltd |
Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
|
|
US20030086940A1
(en)
|
2001-08-10 |
2003-05-08 |
Cristina Costa |
Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
|
|
CA2501295A1
(en)
|
2002-10-02 |
2004-04-15 |
Jack Nguyen |
Methods of generating and screening for proteases with altered specificity
|
|
EP1594541A4
(en)
|
2003-02-21 |
2007-03-28 |
Rikshospitalet Radiumhospitale |
METHOD AND COMPOSITIONS FOR TREATING MECONIUM ASPIRATION SYNDROME
|
|
AU2004216176B2
(en)
|
2003-02-21 |
2008-04-03 |
Genentech, Inc. |
Methods for preventing and treating tissue damage associated with ischemia-reperfusion injury
|
|
US8329169B2
(en)
|
2003-05-15 |
2012-12-11 |
Genentech, Inc. |
Methods and compositions for the prevention and treatment of sepsis
|
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
|
US20050112139A1
(en)
|
2003-10-23 |
2005-05-26 |
Nmk Research, Llc |
Immunogenic composition and method of developing a vaccine based on factor H binding sites
|
|
US8124097B2
(en)
*
|
2004-01-21 |
2012-02-28 |
Case Western Reserve University |
Hybrid and chimeric polypeptides that regulate activation of complement
|
|
JP2005211063A
(ja)
|
2004-01-30 |
2005-08-11 |
Junko Maekuroshima |
ブレンドノニ茶
|
|
US20050169921A1
(en)
|
2004-02-03 |
2005-08-04 |
Leonard Bell |
Method of treating hemolytic disease
|
|
US20050277158A1
(en)
|
2004-06-10 |
2005-12-15 |
Ge Chen |
Method and kit for donor specific complement-fixing antibodies crossmatch
|
|
WO2006012373A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
EP2357254A1
(en)
|
2005-02-14 |
2011-08-17 |
University of Iowa Research Foundation |
Methods and reagents for treatment and diagnosis of age-related macular degeneration
|
|
JP2008540385A
(ja)
|
2005-05-06 |
2008-11-20 |
ラボラトワール セローノ ソシエテ アノニム |
疾患を治療するための免疫グロブリンドメイン含有細胞表面認識分子の使用
|
|
EP2433642B1
(en)
|
2005-10-21 |
2016-12-07 |
Catalyst Biosciences, Inc. |
Modified proteases that inhibit complement activation
|
|
EP3299027A1
(en)
|
2005-11-04 |
2018-03-28 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
|
WO2007149567A2
(en)
|
2006-06-21 |
2007-12-27 |
Musc Foundation For Research Development |
Targeting complement factor h for treatment of diseases
|
|
ATE495447T1
(de)
|
2006-07-03 |
2011-01-15 |
Univ Johns Hopkins |
Peptidantikörperdepletion und anwendung zur probenvorbereitung für massenspektrometrie
|
|
JP5431151B2
(ja)
|
2006-07-13 |
2014-03-05 |
ユニバーシティー オブ アイオワ リサーチ ファンデーション |
血管障害および加齢黄斑変性症の治療および診断のための方法および試薬
|
|
CA2666843C
(en)
|
2006-10-20 |
2015-06-16 |
Celldex Therapeutics, Inc. |
Treatment of age-related macular degeneration and other diseases of the eye
|
|
CN106188303A
(zh)
|
2006-11-02 |
2016-12-07 |
健泰科生物技术公司 |
人源化的抗‑d因子抗体
|
|
GB0701213D0
(en)
|
2007-01-23 |
2007-02-28 |
Univ Cardiff |
Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
|
|
CA2678774A1
(en)
|
2007-03-01 |
2008-09-04 |
Advanced Vision Therapies, Inc. |
Treatment of diseases characterized by inflammation
|
|
GB2447696A
(en)
|
2007-03-23 |
2008-09-24 |
Univ Exeter |
Photonic biosensor arrays
|
|
GB2447698A
(en)
|
2007-03-23 |
2008-09-24 |
Univ Exeter |
Fabrication of photonic biosensor arrays
|
|
BRPI0812767A2
(pt)
|
2007-06-07 |
2014-12-02 |
Genentech Inc |
Anticorpos para c3b e métodos para prevenção e tratamento de distúrbios associados ao complemento
|
|
EP2183573A1
(en)
|
2007-08-10 |
2010-05-12 |
Koninklijke Philips Electronics N.V. |
Sensor array for spr-based detection.
|
|
EP2217720A4
(en)
|
2007-11-01 |
2010-12-08 |
Univ Iowa Res Found |
RNA LOCUS ANALYSIS TO ASSESS THE STUNNING FOR AMD AND MPGNII
|
|
CL2008003241A1
(es)
|
2007-11-02 |
2009-07-31 |
Novartis Ag |
Molecula de enlace que comprende una porcion de enlace de antigeno que se enlaza con un neoepitopo de c3b; composicion farmaceutica que la comprende; y su uso para tratar trastornos oculares
|
|
EP2278987A4
(en)
|
2008-03-28 |
2012-08-22 |
Apellis Ag |
MODULATION AND REPLY / IMPROVEMENT OF THE COMPLEMENTARY SYSTEM IN THE TREATMENT OF TRAUMATISM
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
WO2009151634A1
(en)
|
2008-06-12 |
2009-12-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis
|
|
WO2010027872A1
(en)
|
2008-08-27 |
2010-03-11 |
Children's Hospital & Research Center At Oakland |
Complement factor h-based assays for serum bactericidal activity against neisseria meningitidis
|
|
GB0815576D0
(en)
|
2008-08-28 |
2008-10-01 |
Lucas & Co |
Analysis of glycated proteins
|
|
WO2010034015A2
(en)
|
2008-09-22 |
2010-03-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
|
LT2894165T
(lt)
|
2008-11-10 |
2023-03-10 |
Alexion Pharmaceuticals, Inc. |
Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
|
|
WO2010056399A1
(en)
|
2008-11-17 |
2010-05-20 |
Incode Biopharmaceutics, Inc. |
Method and composition for modulating the immune system and various inflammatory conditions comprising complement depletors
|
|
CN102781471B
(zh)
|
2009-10-16 |
2016-10-12 |
奥默罗斯公司 |
通过抑制masp-2依赖性补体活化治疗弥散性血管内凝血的方法
|
|
MX2012005151A
(es)
|
2009-11-05 |
2012-08-23 |
Federico Ii University Of Naples |
Tratamiento de hemoglobinuria nocturna paroxismica, anemias hemoliticas y estados de enfermedad que involucran hemolisis intravascular y extravascular.
|
|
GB0922659D0
(en)
|
2009-12-24 |
2010-02-10 |
Univ Edinburgh |
Factor H
|
|
WO2011109338A1
(en)
|
2010-03-01 |
2011-09-09 |
Alexion Pharmaceuticals Inc. |
Methods and compositions for treating degos' disease
|
|
CA2791841C
(en)
|
2010-03-05 |
2023-01-03 |
Rigshospitalet |
Chimeric inhibitor molecules of complement activation
|
|
CA2800526C
(en)
|
2010-04-22 |
2018-03-13 |
Ryan Cameron Denomme |
Method and apparatus for an interferometric localized surface plasmon resonance (ilspr) sensor
|
|
WO2011143637A1
(en)
|
2010-05-14 |
2011-11-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Improved complement receptor 2 (cr2) targeting groups
|
|
US9815890B2
(en)
|
2010-06-22 |
2017-11-14 |
The Regents Of The University Of Colorado, A Body Corporate |
Antibodies to the C3d fragment of complement component 3
|
|
US9295713B2
(en)
|
2010-09-15 |
2016-03-29 |
Celldex Therapeutics, Inc. |
Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)
|
|
DK2635704T3
(en)
|
2010-11-01 |
2017-06-19 |
Hoffmann La Roche |
Predicting progression to advanced age-related macular degeneration using a polygenic score
|
|
WO2012095519A1
(en)
|
2011-01-13 |
2012-07-19 |
Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie |
Potent inhibitors of complement activation
|
|
KR101870915B1
(ko)
|
2011-04-08 |
2018-06-25 |
유니버시티 오브 레스터 |
Ｍａｓｐ-2 의존적 보체 활성화와 관련된 질병을 치료하는 방법
|
|
BR112014013205A2
(pt)
*
|
2011-12-01 |
2020-10-27 |
Protevobio, Inc. |
proteína de fusão, seu uso e seu método de produção, composição farmacêutica, ácido nucleico, e kit
|
|
AU2013243948A1
(en)
*
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US10245229B2
(en)
|
2012-06-08 |
2019-04-02 |
Translate Bio, Inc. |
Pulmonary delivery of mRNA to non-lung target cells
|
|
EP4331620A3
(en)
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
AU2014209350B8
(en)
|
2013-01-23 |
2019-04-18 |
Department Of Veterans Affairs (Us) |
Targeting constructs based on natural antibodies and uses thereof
|
|
GB201301632D0
(en)
|
2013-01-30 |
2013-03-13 |
Imp Innovations |
Complement System
|
|
CA3216595A1
(en)
|
2013-03-14 |
2014-10-02 |
Kevin Fitzgerald |
Complement component c5 irna compositions and methods of use thereof
|
|
WO2014194213A1
(en)
|
2013-05-30 |
2014-12-04 |
University Of Iowa Research Foundation |
Specific complement proteins and efficacy of antibody therapy
|
|
US10183988B2
(en)
|
2013-06-07 |
2019-01-22 |
Duke University |
Anti-Complement factor H antibodies
|
|
US20160184391A1
(en)
|
2013-08-16 |
2016-06-30 |
Alexion Pharmaceuticals, Inc. |
Treatment of graft rejection by administering a complement inhibitor to an organ prior to transplant
|
|
CN104231085B
(zh)
|
2013-09-05 |
2017-03-15 |
复旦大学附属肿瘤医院 |
靶向特异性补体系统抑制剂、其制备方法及应用
|
|
GB201318170D0
(en)
|
2013-10-14 |
2013-11-27 |
Univ Edinburgh |
Proteins with Diagnostic and Therapeutic Uses
|
|
MX2016005238A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Formulaciones de lipidos para la administracion de acido ribonucleico mensajero.
|
|
FR3015484A1
(fr)
*
|
2013-12-20 |
2015-06-26 |
Lab Francais Du Fractionnement |
Proteines recombinantes possedant une activite de facteur h
|
|
WO2016022914A1
(en)
|
2014-08-08 |
2016-02-11 |
Moderna Therapeutics, Inc. |
Compositions and methods for the treatment of ophthalmic diseases and conditions
|
|
MX378112B
(es)
|
2014-08-20 |
2025-03-10 |
Stichting Sanquin Bloedvoorziening |
Anticuerpos que potencian el factor h y sus usos.
|
|
WO2016068616A1
(ko)
|
2014-10-29 |
2016-05-06 |
차의과학대학교 산학협력단 |
C3 또는 c1r 보체를 분비하는 태반 유래 세포 및 이를 포함하는 조성물
|
|
US20210318287A1
(en)
|
2015-02-16 |
2021-10-14 |
The Regents Of The University Of Michigan |
Localized surface plasmon resonance sensor systems and methods
|
|
HK1250011A1
(zh)
|
2015-03-31 |
2018-11-23 |
Sorriso Pharmaceuticals, Inc. |
具有蛋白酶可切割接头的肽构建体
|
|
CN108291216B
(zh)
*
|
2015-09-24 |
2022-09-16 |
宾夕法尼亚州大学信托人 |
用于治疗补体介导的疾病的组合物和方法
|
|
WO2017181021A1
(en)
|
2016-04-15 |
2017-10-19 |
Regenxbio Inc. |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
GB201608046D0
(en)
|
2016-05-09 |
2016-06-22 |
Cambridge Entpr Ltd And Syndey Children S Hospitals Network Randwick And Westmead Incorporating The |
Treatment of complement-mediated disorders
|
|
CN109689084A
(zh)
|
2016-06-28 |
2019-04-26 |
乌尔姆大学 |
补体抑制剂及其用途
|
|
GB201709222D0
(en)
|
2017-06-09 |
2017-07-26 |
Univ Manchester |
C3b Inactivating Polypeptide
|
|
US11442067B2
(en)
|
2017-07-25 |
2022-09-13 |
Biocon Limited |
Peptide mapping method for sequence identification of insulin and insulin analogues
|
|
GB201800620D0
(en)
|
2018-01-15 |
2018-02-28 |
Univ Manchester |
C3b Binding Polypeptide
|
|
IL277106B2
(en)
|
2018-03-13 |
2024-03-01 |
Amgen Inc |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
EP3791180A1
(en)
|
2018-05-10 |
2021-03-17 |
The University Of Manchester |
Methods for assessing macular degeneration
|
|
SI3793586T1
(sl)
|
2018-05-16 |
2024-07-31 |
Csl Limited |
Različice receptorja za topni komplement tipa 1 in njihova uporaba
|
|
GB2583560A
(en)
|
2018-12-11 |
2020-11-04 |
Admirx Inc |
Fusion protein constructs for complement associated disease
|
|
GB201821082D0
(en)
|
2018-12-21 |
2019-02-06 |
Gyroscope Therapeutics Ltd |
Combination of complement factors i and h, and vector encoding thereof
|
|
CA3141778A1
(en)
|
2019-06-12 |
2020-12-17 |
CSL Innovation Pty Ltd |
Soluble complement receptor type 1 variant conjugates and uses thereof
|
|
GB202006789D0
(en)
|
2020-05-07 |
2020-06-24 |
Univ Manchester |
Detection of complement proteins
|
|
GB202007353D0
(en)
|
2020-05-18 |
2020-07-01 |
Shaw Andrew |
Viral infection characterization
|
|
US20210373009A1
(en)
|
2020-05-28 |
2021-12-02 |
University Of North Texas |
Plasmonic meta-surface based molecular sensors and methods for making and using them
|
|
MX2023004377A
(es)
|
2020-10-16 |
2023-06-28 |
Gyroscope Therapeutics Ltd |
Acido nucleico que codifica una entidad anti-vegf y un regulador del complemento negativo y sus usos para el tratamiento de la degeneracion macular relacionada con la edad.
|